Key result
Rheumatoid arthritis in Romania generated average indirect costs of 1506€ per patient annually, significantly lower than in other countries due to the low monetary value of paid work.
Observational (n=206)
The indirect costs of rheumatoid arthritis in Romania are estimated at 1506€ per patient annually, which is lower than in other countries primarily due to the lower monetary value of paid work.
May guide local RA resource planning in low-wage economies; leaves open generalizability of indirect cost estimates across Europe.
Rheumatoid arthritis (RA) is associated with increased costs generated by resource utilization and loss of work productivity. We have studied 206 RA patients and analyzed indirect costs of RA in Romania (estimated using the human capital approach) in comparison with reported data for other countries. Data were collected using self-reported questionnaires. The average age at inclusion was 55 years, with mean disease duration of 9.4 years; 55 patients had permanent work disability due to RA; 6.35 days of sick leave per patient were reported for the entire year of follow-up; the cost of permanent work disability was 1256€ per patient. From a societal perspective, the average indirect costs for a patient with RA were 1506€, significantly lower than the ones reported by other countries, especially due to the low monetary value of paid work.
No takes yet. Share an insight, caveat, or question.
Codreanu et al. (2019) conducted an observational in Rheumatoid arthritis (n=206). Rheumatoid arthritis vs. Reported data for other countries was evaluated on Average indirect costs from a societal perspective. Rheumatoid arthritis in Romania generated average indirect costs of 1506€ per patient annually, significantly lower than in other countries due to the low monetary value of paid work.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: